From September 1, Alma UK will be the exclusive distributor of Revanesse and SoftFil across the UK.
Alma UK, a leading provider in advanced medical aesthetics solutions, has announced a new collaboration with Prollenium Medical Technologies, the innovators behind Revanesse, the renowned dermal fillers collection.
The new partnership merges Alma’s energy-based devices with Revanesse’s injectable treatments, ensuring optimal outcomes for clinics and their patients. As part of this strategic alliance, the Prollenium UK team will now join Alma UK, forming the new Alma Injectables Division in the UK. This division will focus on providing comprehensive solutions to clinics, underpinned by Alma and Prollenium’s customer-centric approach.
The addition of Revanesse and SoftFil to Alma’s extensive range of products underscores the company’s commitment to providing cutting-edge, scientifically backed technologies.
Revanesse’s spherical particles offer smoother, natural results with less swelling and discomfort. In a head-to-head clinical trial, a higher percentage of subjects treated with other brands reported pain at the injection site compared to those treated with Revanesse Ultra. Similar findings were noted for swelling, with more subjects in the competitor group experiencing injection site swelling than those in the Revanesse Ultra group1. This level of performance exemplifies the advanced technology and research behind the Revanesse collection, which includes a comprehensive range of dermal fillers such as Revanesse Revise, Revanesse Kiss, Revanesse Ultra, Revanesse Contour, Revanesse Outline, and Revanesse Shape.
To ensure that clinics are fully equipped to utilise these new products, Alma will provide state-of-the-art training and ongoing support through Harley Academy as well as its training facilities in London, which offer stunning views of St Paul’s Cathedral. Alma’s Global Academies and innovative UK Clinic Marketing Accelerator Programme will further support clinics in achieving exceptional patient outcomes and business growth.
Ario Khoshbin, chief executive of Prollenium announced, “By partnering with Alma UK, we’re combining our strengths to offer clinics a powerful synergy of advanced injectables and cutting-edge energy-based technologies, ultimately enhancing patient outcomes and clinic success.”
Lior Dayan, chief executive of Alma and Sisram added, “The strategic partnership with Prollenium and the introduction of Revanesse will allow us to bring a new era of innovation to the medical aesthetics industry. Together, we are empowered to pioneer cutting-edge solutions by delivering high-end injectable products and proprietary technologies.”
He continued, “The UK is a strategic territory for Alma, and we are excited to bring to the kingdom a high-end injectables collection that will increase patient lifetime value and completely redefine the experience of beauty-seekers in the territory.”
For more information on this new partnership please contact the Alma team by emailing [email protected], phoning 0808 304 5676 or visiting almalasers.co.uk.
This is a sponsored post in association with Alma.
Alma UK, a leading provider in advanced medical aesthetics solutions, has announced a new collaboration with Prollenium Medical Technologies, the innovators behind Revanesse, the renowned dermal fillers collection.
The new partnership merges Alma’s energy-based devices with Revanesse’s injectable treatments, ensuring optimal outcomes for clinics and their patients. As part of this strategic alliance, the Prollenium UK team will now join Alma UK, forming the new Alma Injectables Division in the UK. This division will focus on providing comprehensive solutions to clinics, underpinned by Alma and Prollenium’s customer-centric approach.
The addition of Revanesse and SoftFil to Alma’s extensive range of products underscores the company’s commitment to providing cutting-edge, scientifically backed technologies.
Revanesse’s spherical particles offer smoother, natural results with less swelling and discomfort. In a head-to-head clinical trial, a higher percentage of subjects treated with other brands reported pain at the injection site compared to those treated with Revanesse Ultra. Similar findings were noted for swelling, with more subjects in the competitor group experiencing injection site swelling than those in the Revanesse Ultra group1. This level of performance exemplifies the advanced technology and research behind the Revanesse collection, which includes a comprehensive range of dermal fillers such as Revanesse Revise, Revanesse Kiss, Revanesse Ultra, Revanesse Contour, Revanesse Outline, and Revanesse Shape.
To ensure that clinics are fully equipped to utilise these new products, Alma will provide state-of-the-art training and ongoing support through Harley Academy as well as its training facilities in London, which offer stunning views of St Paul’s Cathedral. Alma’s Global Academies and innovative UK Clinic Marketing Accelerator Programme will further support clinics in achieving exceptional patient outcomes and business growth.
Ario Khoshbin, chief executive of Prollenium announced, “By partnering with Alma UK, we’re combining our strengths to offer clinics a powerful synergy of advanced injectables and cutting-edge energy-based technologies, ultimately enhancing patient outcomes and clinic success.”
Lior Dayan, chief executive of Alma and Sisram added, “The strategic partnership with Prollenium and the introduction of Revanesse will allow us to bring a new era of innovation to the medical aesthetics industry. Together, we are empowered to pioneer cutting-edge solutions by delivering high-end injectable products and proprietary technologies.”
He continued, “The UK is a strategic territory for Alma, and we are excited to bring to the kingdom a high-end injectables collection that will increase patient lifetime value and completely redefine the experience of beauty-seekers in the territory.”
For more information on this new partnership please contact the Alma team by emailing [email protected], phoning 0808 304 5676 or visiting almalasers.co.uk.
This is a sponsored post in association with Alma.
